Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professors Irina Udalova and Paul Bowness have been selected to the British Society for Immunology (BSI) Congress Committee, starting in October 2016.

The BSI is the largest society in Europe and one of the oldest, largest, and most active immunology societies in the world. Its main objective is to promote and support excellence in research, scholarship and clinical practice in immunology for the benefit of human and animal health and welfare.

The committee is tasked with the planning and delivery of the BSI's Annual Congress, their flagship event which attracts over 1,000 delegates from around the world. The committee leads on drawing up the programme, selecting invited speakers and reviewing submitted abstracts as well as having responsibility for budget planning and overall conference organisation.

Professor Udalova said: "I am very pleased to join the BSI Congress committee. I thoroughly enjoyed shaping the Macrophage biology session for the BSI 2014 congress and felt I could contribute more to planning and delivery of future congresses. These congresses have been invaluable for exposing students and young scientists to the cutting edge questions in immunology and for fostering their interactions with peers throughout the UK."

"The British Society for Immunology (BSI) is now in its 60th year and remains at the forefront of education and discussion in the field of immunology, with its congress the flagship scientific and educational event. I am delighted to be given the opportunity to help shape this going forward." added Professor Bowness.

Both Professors Udalova and Bowness are due to attend their first meeting of the Congress Committee in October, joining the 16 member committee as their terms of office officially start.

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.